The phrase "agent regimen" is not commonly used in written English and may not be widely recognized.
It could be used in contexts related to medical or pharmaceutical discussions, particularly when referring to a specific treatment plan involving an agent.
Example: "The doctor prescribed an agent regimen to effectively manage the patient's condition."
Alternatives: "treatment plan" or "medication schedule".
bIncludes patients receiving at least one dose of antibiotics irrespective of agent, regimen or administration route.
We have identified a first generation ATG4B antagonist that effectively suppresses autophagy in vivo and in a single agent regimen effectively inhibits the growth of Saos-2 tumors in preclinical xenograft models.
Eligible patients had A1C >7.5%, were either already receiving insulin or on a maximal oral agent regimen, were aged >41 years, and had no major cardiovascular events during the 6 months before enrollment.
Furthermore, no studies have adequately evaluated fracture reduction with combined anti-resorptive/anabolic agent regimens.
Further analysis indicated a possible clinical benefit from the addition of an anthracycline to cisplatin alkylating agent regimens.
97% of patients who received postoperative chemotherapy underwent platinum based mono- (51%) or multi- (46%) agent regimens while 3% patients received non platinum-based chemotherapy regimens.
By contrast, 59 subjects (16.3%) in Group 2 did not add any new oral or insulin regimen at baseline and only optimized their current oral agent regimens.
Paclitaxel platinum combinations are therefore replacing platinum-alkylating agent regimens as standard first-line therapy in advanced ovarian cancer (Kaye, 2000).
Three bridging agent regimens were evaluated: LMWH or other pentasaccharide (e.g. fondaparinux) [LMWH/PS]; unfractionated heparin (UFH) [excluding UFH used for line flushing]; and two-agent bridging (LMWH/PS and UFH).
Complex multiple agent regimens are used with the aim of rapidly restoring bone marrow function, preventing the development of resistant cell lines and treating sanctuary sites such as the CNS as relapse is associated with a poor prognosis.
In contrast to traditional single agent regimens, when leflunomide is used as an adjunct to methotrexate or the other DMARD components of 'triple therapy', lower doses are often used initially and for continuing therapy.
